Kalehua Capital Management LLC
DALLAS, TX · CIK 2106181 · 13F filing filed 2026-02-13
Exempt reporting adviser since 2023 · limited liability company
- Private funds2 · $130.8m gross assets
- Websitekalehuacapital.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityKALEHUA CAPITAL MANAGEMENT LLC (US)
$101.1m
reported value
19positions
83.5%in top 10
—no comparable previous quarter
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| EA SERIES TRUST BOXX | $26.6m26.27% | First filing |
| X4 PHARMACEUTICALS INC XFOR | $14.9m14.73% | First filing |
| SIONNA THERAPEUTICS INC SION | $8.1m8.02% | First filing |
| RELAY THERAPEUTICS INC RLAY | $7.6m7.54% | First filing |
| COMPASS PATHWAYS PLC CMPS | $5.7m5.59% | First filing |
| PHARVARIS N V PHVS | $5.5m5.46% | First filing |
| SEPTERNA INC SEPN | $5.4m5.36% | First filing |
| ORUKA THERAPEUTICS INC ORKA | $3.6m3.55% | First filing |
| INHIBIKASE THERAPEUTICS INC IKT | $3.6m3.55% | First filing |
| ALLOGENE THERAPEUTICS INC ALLO | $3.5m3.45% | First filing |
| LEONABIO INC LONA | $3.0m2.95% | First filing |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $2.3m2.29% | First filing |
| ORIC PHARMACEUTICALS INC ORIC | $2.2m2.16% | First filing |
| VERRICA PHARMACEUTICALS INC VRCA | $2.0m1.94% | First filing |
| TYRA BIOSCIENCES INC TYRA | $2.0m1.94% | First filing |
| SURROZEN INC SRZN | $1.9m1.87% | First filing |
| TENAYA THERAPEUTICS INC TNYA | $1.4m1.41% | First filing |
| KALARIS THERAPEUTICS INC KLRS | $1.2m1.17% | First filing |
| DIAMEDICA THERAPEUTICS INC DMAC | $759.1k0.75% | First filing |